The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Nivolumab and ipilimumab for second-line therapy in elderly patients with advanced esophageal squamous cell cancer: Safety interim analysis of the RAMONA trial.
 
Nicolai Hartel
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb
 
Nadja M Meindl-Beinker
Employment - IQVIA; Seqirus
 
Martin Maenz
Stock and Other Ownership Interests - Tilray
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Roche (Inst)
 
Wolfgang Hiegl
Stock and Other Ownership Interests - Merck Serono; Roche
 
Johannes Betge
No Relationships to Disclose
 
Ralf Dieter Hofheinz
Honoraria - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Ipsen; Lilly; Medac; Merck; MSD; Roche; Saladax Biomedical; Sanofi; SERVIER
Consulting or Advisory Role - Amgen; AstraZeneca; Bayer; Boehringer Ingelheim; Bristol-Myers Squibb; Merck; MSD; Roche; Saladax Biomedical; Sanofi; SERVIER
Research Funding - Amgen (Inst); Medac (Inst); Merck (Inst); Roche (Inst); Sanofi (Inst)
 
Arndt Vogel
Honoraria - Amgen; Bristol-Myers Squibb; Ipsen; Janssen; Lilly; MSD; Novartis; Pierre Fabre; Roche; Sanofi
Consulting or Advisory Role - Amgen; AstraZeneca; Baxalta; Bayer; BTG; Eisai; IPSEN; Lilly; Novartis; Pierre Fabre; Roche
Research Funding - Novartis
Travel, Accommodations, Expenses - Bayer; Ipsen; Roche
 
Stefan Angermeier
No Relationships to Disclose
 
Claus Bolling
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); PledPharma (Inst)
 
Maike de Wit
Consulting or Advisory Role - Abbvie; AstraZeneca; Boehringer Ingelheim; Ipsen; Jazz Pharmaceuticals
Speakers' Bureau - AstraZeneca; Daiichi Sankyo; Ipsen; Janssen; MSD; Nutricia; Sanofi
Research Funding - Abbvie (Inst); Amgen (Inst); AstraZeneca (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Genzyme (Inst); Ipsen (Inst); Janssen (Inst); MorphoSys (Inst); MSD (Inst); Noona Healthcare (Inst); Novartis (Inst); Nucana (Inst); Pfizer (Inst); Pierre Fabre (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Astellas Pharma; AstraZeneca; Pfizer; Takeda
 
Ralf Jakobs
Honoraria - Boston Scientific; Falk Foundation; Merck; Roche
Consulting or Advisory Role - Amgen; Bayer Health; Bristol-Myers Squibb
 
Meinolf Karthaus
No Relationships to Disclose
 
Gertraud Stocker
Consulting or Advisory Role - Amgen; Bayer Health; Bristol-Myers Squibb
 
Peter C. Thuss-Patience
Research Funding - Merck Serono (Inst)
 
Matthias Philip Ebert
Consulting or Advisory Role - Bristol-Myers Squibb; MSD
Speakers' Bureau - Bristol-Myers Squibb
Research Funding - Bristol-Myers Squibb (Inst)